Last month Boku was covered here as a company which is "ripe for takeover" in a Stock Focus special: https://zakstraderscafe.com/stock-focus-boku-boku-ripe-for-takeover/12075/…
Zevra Therapeutics (NASDAQ:ZVRA): "Multiple Approaches" Sources familiar with the situation say the company has had multiple approaches around $20. They…